feed,title,long_url,short_url
MarketWatch,Karyopharm Therapeutics upgraded to neutral from underweight at J.P. Morgan,http://www.marketwatch.com/tools/quotes/quotes.asp?symb=KPTI&siteid=rss,https://on.mktw.net/3B7ac0K
MarketWatch,Cvent started at neutral with $8 stock price target at J.P. Morgan,http://www.marketwatch.com/tools/quotes/quotes.asp?symb=CVT&siteid=rss,https://on.mktw.net/3BaA385
